Design of lipid-based formulations for oral administration of poorly water-soluble drug fenofibrate: Effects of digestion

AAPS PharmSciTech

Volumn 13, Issue 2, 2012, Pages 637-646

  Mohsin, Kazi ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

fenofibrate; in vitro lipolysis; lipid formulation classification system; self emulsifying microemulsifying drug delivery systems (SEDDS, SMEDDS)

Indexed keywords

ACYLGLYCEROL; BILE SALT; FATTY ACID; FENOFIBRATE; SURFACTANT;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIGESTION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG EFFECT; DRUG FORMULATION; DRUG SOLUBILITY; IN VITRO STUDY; INTESTINE FLUID; LIPOLYSIS; PH; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; BILE ACIDS AND SALTS; CHEMISTRY, PHARMACEUTICAL; DIGESTION; DRUG CARRIERS; DRUG DESIGN; EXCIPIENTS; FATTY ACIDS; FENOFIBRATE; GLYCERIDES; HYDROGEN-ION CONCENTRATION; HYPOLIPIDEMIC AGENTS; INTESTINAL ABSORPTION; INTESTINAL SECRETIONS; KINETICS; LIPASE; LIPIDS; LIPOLYSIS; PANCREAS; SOLUBILITY; SOLVENTS; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84862898541     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9787-2     Document Type: Article

References (31)

1. K Kohli S Chopra D Dhar S Arora RK Khar 2010 Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability Drug Discovery Today 15 21-22 958 965 20727418 10.1016/j.drudis.2010.08.007 1:CAS:528:DC%2BC3cXhsVWmsrfL
2. M Kuentz 2011 Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects J Drug Deliv Sci Technol 21 1 17 26 1:CAS:528:DC%2BC3MXjslClt7k%3D
3. AM Kaukonen BJ Boyd WN Charman CJ Porter 2004 Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids Pharm Res 21 2 254 260 15032306 10.1023/B:PHAM.0000016283.87709.a9 1:CAS:528:DC%2BD2cXhtlWqsbo%3D (Pubitemid 38221970)
4. PP Constantinides 1995 Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm Res 12 11 1561 1572 8592652 10.1023/A:1016268311867 1:CAS:528:DyaK2MXpslCqsrs%3D (Pubitemid 26005509)
5. CW Pouton 2000 Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur J Pharm Sci 11 Suppl 2 S93 S98 11033431 10.1016/S0928-0987(00)00167- 6 1:CAS:528:DC%2BD3cXntF2gur4%3D
6. WN Charman 2000 Lipids, lipophilic drugs, and oral drug delivery-some emerging concepts J Pharm Sci 89 8 967 978 10906720 10.1002/1520-6017(200008)89: 8<967::AID-JPS1>3.0.CO;2-R 1:CAS:528:DC%2BD3cXmtVWms7c%3D
7. DG Fatouros B Bergenstahl A Mullertz 2007 Morphological observations on a lipid-based drug delivery system during in vitro digestion Eur J Pharm Sci 31 2 85 94 17418543 10.1016/j.ejps.2007.02.009 1:CAS:528:DC%2BD2sXkvFyqu7c%3D (Pubitemid 46660577)
8. WH Lim MJ Lawrence 2004 Influence of surfactant and lipid chain length on the solubilisation of phosphatidylcholine vesicles by micelles comprised of polyoxyethylene sorbitan monoesters Colloid Surf A 250 1-3 449 457 10.1016/j.colsurfa.2004.06.042 1:CAS:528:DC%2BD2cXhtVKlurfN (Pubitemid 39610822)
9. WH Lim MJ Lawrence 2004 Aggregation behaviour of mixtures of phosphatidylcholine and polyoxyethylene sorbitan monoesters in aqueous solution Phys Chem Chem Phys 6 7 1380 1387 10.1039/b314610n 1:CAS:528: DC%2BD2cXisVers74%3D
10. H Ljusberg-Wahren F Seier Nielsen M Brogard E Troedsson A Mullertz 2005 Enzymatic characterization of lipid-based drug delivery systems Int J Pharm 298 2 328 332 15979260 10.1016/j.ijpharm.2005.02.038 1:CAS:528:DC%2BD2MXlvV2nu78%3D (Pubitemid 40910737)
11. Y Li M Hu DJ McClements 2011 Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: proposal for a standardised pH-stat method Food Chem 126 2 498 505 10.1016/j.foodchem.2010.11.027 1:CAS:528:DC%2BC3cXhs1SrurvP
12. CW Pouton 2006 Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur J Pharm Sci 29 3-4 278 287 16815001 10.1016/j.ejps.2006.04.016 1:CAS:528:DC%2BD28XhtFentrrM (Pubitemid 44740131)
13. K Mohsin MA Long CW Pouton 2009 Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution J Pharm Sci 98 10 3582 3595 19130605 10.1002/jps.21659 1:CAS:528:DC%2BD1MXhtVKhsr7K
14. PP Constantinides J-P Scalart C Lancaster J Marcello G Marks H Ellens, et al. 1994 Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides Pharmaceut Res 11 10 1385 1390 10.1023/A:1018927402875 1:CAS:528:DyaK2MXivFaltLk%3D (Pubitemid 24339642)
15. T Gershanik S Benita 2000 Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs Eur J Pharm Biopharm 50 1 179 188 10840200 10.1016/S0939-6411(00)00089-8 1:CAS:528:DC%2BD3cXjslyisrk%3D (Pubitemid 30326696)
16. M Brogard E Troedsson K Thuresson H Ljusberg-Wahren 2007 A new standardized lipolysis approach for characterization of emulsions and dispersions J Colloid Interface Sci 308 2 500 507 17289070 10.1016/j.jcis.2006. 12.015 1:CAS:528:DC%2BD2sXitlGgu7c%3D
17. JF Cuine CL McEvoy WN Charman CW Pouton GA Edwards H Benameur, et al. 2008 Evaluation of the impact of surfactant digestion on the bioavailability of danazol after oral administration of lipidic self-emulsifying formulations to dogs J Pharm Sci 97 2 993 1010 10.1002/jps.21246 (Pubitemid 351293898)
18. AT Larsen P Sassene A Mullertz 2011 In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems Int J Pharm 417 1-2 245 255 21392564 10.1016/j.ijpharm.2011.03.002 1:CAS:528:DC%2BC3MXhtVygsL%2FF
19. FJ Alvarez VJ Stella 1989 The role of calcium ions and bile salts on the pancreatic lipase-catalyzed hydrolysis of triglyceride emulsions stabilized with lecithin Pharm Res 6 6 449 457 2762220 10.1023/A:1015956104500 1:CAS:528:DyaL1MXkvVeqtLc%3D
20. KJ MacGregor JK Embleton JE Lacy EA Perry LJ Solomon H Seager, et al. 1997 Influence of lipolysis on drug absorption from the gastro-intestinal tract Adv Drug Deliver Rev 25 1 33 46 10.1016/S0169-409X(96)00489-9 1:CAS:528:DyaK2sXhtlOqsrY%3D (Pubitemid 27107789)
21. L Sek CJ Porter WN Charman 2001 Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situ densitometric analysis J Pharm Biomed Anal 25 3-4 651 661 11377046 10.1016/S0731-7085(00)00528-8 1:CAS:528:DC%2BD3MXjslelurw%3D (Pubitemid 32493922)
22. L Sek CJ Porter AM Kaukonen WN Charman 2002 Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic products J Pharm Pharmacol 54 1 29 41 11833493 10.1211/0022357021771896 1:CAS:528:DC%2BD38XhtlWru78%3D (Pubitemid 34116220)
23. E Jurado M Fernandez-Serrano J Nunez-Olea G Luzon M Lechuga 2006 Simplified spectrophotometric method using methylene blue for determining anionic surfactants: applications to the study of primary biodegradation in aerobic screening tests Chemosphere 65 2 278 285 16616296 10.1016/j.chemosphere. 2006.02.044 1:CAS:528:DC%2BD28Xot1Wqt74%3D (Pubitemid 44163357)
24. JF Cuine WN Charman CW Pouton GA Edwards CJ Porter 2007 Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs Pharm Res 24 4 748 757 17372700 10.1007/s11095-006-9194-z 1:CAS:528:DC%2BD2sXivVSgsro%3D (Pubitemid 46411963)
25. TS Wiedmann L Kamel 2002 Examination of the solubilization of drugs by bile salt micelles J Pharm Sci 91 8 1743 1764 12115803 10.1002/jps.10158 1:CAS:528:DC%2BD38XlvV2ks74%3D (Pubitemid 34810521)
26. A Dahan A Hoffman 2006 Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats Pharm Res 23 9 2165 2174 16902814 10.1007/s11095-006-9054-x 1:CAS:528:DC%2BD28XptVaitro%3D
27. JO Christensen K Schultz B Mollgaard HG Kristensen A Mullertz 2004 Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols Eur J Pharm Sci 23 3 287 296 15489130 10.1016/j.ejps.2004.08.003 1:CAS:528:DC%2BD2cXos1ersbw%3D (Pubitemid 39369884)
28. CW Pouton 1997 Formulation of self-emulsifying drug delivery systems Adv Drug Deliver Rev 25 1 47 58 10.1016/S0169-409X(96)00490-5 1:CAS:528: DyaK2sXhtlOqsrc%3D (Pubitemid 27107790)
29. J Najib 2002 Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet formulation Clin Ther 24 12 2022 2050 12581543 10.1016/S0149-2918(02)80095-9 1:CAS:528: DC%2BD3sXps1Gltg%3D%3D (Pubitemid 36051529)
30. AJ Humberstone WN Charman 1997 Lipid based vehicles for the oral delivery of poorly water soluble drugs Adv Drug Deliv Rev 25 1 103 128 10.1016/S0169-409X(96)00494-2 1:CAS:528:DyaK2sXhtlOqs70%3D
31. VS Narayanan J Storch 1996 Fatty acid transfer in taurodeoxycholate mixed micelles Biochemistry 35 23 7466 7473 8652524 10.1021/bi952979k 1:CAS:528:DyaK28XjtVCiu7k%3D (Pubitemid 26189812)